UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported):
(Exact Name of Registrant as Specified in Charter)
(State or Other Jurisdiction | (Commission | (IRS Employer |
(Address of Principal Executive Offices) | (Zip Code) |
Registrant’s telephone number, including area code: (
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading | Name of each exchange on which registered | ||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.07. Submission of Matters to a Vote of Security Holders.
The Annual Meeting of Stockholders of Verastem, Inc. (the “Company”) was held in Needham, Massachusetts on May 12, 2022. At that meeting, the stockholders considered and acted upon the following proposals:
Proposal No. 1 — Election of Class I Directors. By the vote reflected below, the stockholders elected the following individuals to serve as Class I directors until the 2025 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified:
Name |
| Votes For |
| Votes Withheld |
| Broker Non-Votes |
John Johnson | 68,196,675 | 27,238,280 | 38,414,236 | |||
Michael Kauffman, M.D. | 80,604,317 | 14,830,638 | 38,414,236 | |||
Eric Rowinsky, M.D. | 57,330,156 | 38,104,799 | 38,414,236 |
Proposal No. 2 — The Ratification of the Selection of Ernst & Young LLP as the Company’s Independent Registered Public Accounting Firm for the Current Fiscal Year. The stockholders voted to ratify the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the current fiscal year. 133,305,323 shares voted for the proposal; 191,900 shares voted against the proposal; and 351,968 shares abstained from voting on the proposal. There were no broker non-votes on the proposal.
Proposal No. 3 — Non-Binding Advisory Vote on the Compensation of the Company’s Named Executive Officers. The Company’s stockholders approved, on a non-binding, advisory basis, the compensation paid to the Company’s named executive officers. 89,933,554 shares voted for the proposal; 5,125,119 shares voted against the proposal; and 376,282 shares abstained from voting on the proposal. There were 38,414,236 broker non-votes on the proposal.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
VERASTEM, INC. | ||
Dated: May 16, 2022 | By: | /s/ Brian M. Stuglik |
Brian M. Stuglik | ||
Chief Executive Officer |